Breaking News Headlines Today

News about Merck

Stay current with all the latest and breaking news about Merck, compare headlines and perspectives between news sources on stories happening today. In total, 28 stories have been published about Merck which Ground News has aggregated in the past 3 months.

Covered Most By

Local News Publishers

Suggest a source

Looking for a source we don't already have? Suggest one here.

Top Merck News

Merck · United States

Merck urges science-led US vaccine schedule after CDC trims childhood vaccine list

84% Center coverage: 12 sources

Merck on Thursday said any changes to the U.S. child and adolescent immunization schedule should rest on comprehensive data and guidance from vaccine experts, after federal health officials shifted several shots out of the "universally recommended" category.See the Story

Donald Trump · United States

Trump Struck Deals with 16 Drug Companies. But They’re Still Raising Prices This Year

67% Left coverage: 3 sources

All 16 drug companies that inked deals with the Trump administration over the past few months still raised some of their prices for 2026.See the Story

Merck · San Diego

BMS Tries Again With T Cell Engagers, Turning to Janux to Develop New Tumor-Activated Therapy

100% Center coverage: 2 sources

Bristol Myers Squibb is paying $50 million to begin a collaboration with Janux Therapeutics, a company that develops T cell engagers that activate specifically at the site of the tumor. It’s the second big pharma alliance for Janux, which has been working with Merck. The post BMS Tries Again With T Cell Engagers, Turning to Janux to Develop New Tumor-Activated Therapy appeared first on MedCity News.See the Story

BMS Tries Again With T Cell Engagers, Turning to Janux to Develop New Tumor-Activated Therapy

100% Center coverage: 2 sources

Global Blockbuster Drug Landscape Shifts in 2026: Keytruda Defends No. 1, “Diabesity” Rivals Surge, IRA Price Caps Take Effect

2026 is framed as a pivotal turning point for the pharmaceutical industry. The market is being reshaped by three concurrent forces: Merck’s Keytruda sustaining its … [Illustrations] Global Blockbuster Drug Landscape Shifts in 2026: Keytruda Defends No. 1, “Diabesity” Rivals Surge, IRA Price Caps Take Effect Read More » The post [Illustrations] Global Blockbuster Drug Landscape Shifts in 2026: Keytruda Defends No. 1, “Diabesity” Rivals Surge, IRA…Merck Read Article

Merck CEO on US Business, Life Sciences Innovation

100% Left coverage: 1 sources

Merck KGaA Chief Executive Officer Belen Garijo says the company will continue to collaborate with the US and deliver life sciences innovation to patients. She spoke to Bloomberg's Francine Lacqua on the sidelines of the 2026 World Economic Forum in Davos, Switzerland. (Source: Bloomberg)Merck · Davos Read Article

Liz Weston: What Is a ‘Advanced Designation Representative’ and Must I Choose One?

100% Center coverage: 2 sources

Dear Liz: My question has to do with a bulletin put out by the Social Security Administration last year requiring people with Social Security income to submit the name of a person to be their advanced designation representative.Coca-Cola · United States See the Story

Dow Jones Today: Dow slips as options expiry hits and investors weigh bank earnings

New York, Jan 16, 2026, 10:02 ET — Regular session The Dow Jones Industrial Average dipped in early Friday trading, erasing a modest gain from the open as declines in healthcare and consumer sectors weighed on the index. Around 10 a.m. ET, the Dow was down 70.37 points, or 0.14%, at 49,372.07. The S&P 500 edged up 0.07%, while the Nasdaq Composite climbed 0.26%. Among the Dow’s biggest losers were Salesforce, Merck, and UnitedHealth, with Nvidia…Salesforce · New York Read Article

Trump Struck Deals with 16 Drug Companies. But They’re Still Raising Prices This Year

67% Left coverage: 3 sources

All 16 drug companies that inked deals with the Trump administration over the past few months still raised some of their prices for 2026.Donald Trump · United States See the Story

JPM: Illumina Launches 'Unprecedented' Disease Biology Atlas

100% Center coverage: 3 sources

Illumina says its new Billion Cell Atlas can be used to identify and validate drug targets and train AI models used in drug discovery.Eli Lilly · San Diego See the Story

Merck urges science-led US vaccine schedule after CDC trims childhood vaccine list

84% Center coverage: 12 sources

Merck in Talks to Buy Biotech Revolution in up to $32 Billion Deal, FT Reports

66% Center coverage: 6 sources

Merck is in talks to buy cancer drug developer Revolution Medicines in a $28 billion to $32 billion deal, the Financial Times reported on Thursday, citing a person familiar with the matter.Finance · United States See the Story

Trump Announces Lower Drug Price Deals With 9 Pharmaceutical Companies

55% Center coverage: 11 sources

(MedPage Today) -- President Trump announced on Friday that nine drugmakers have agreed to lower the cost of their prescription drugs in the U.S. Pharmaceutical companies Amgen, Bristol Myers Squibb, Boehringer Ingelheim, Genentech, Gilead Sciences...Donald Trump · United States See the Story

News about Merck

News about Merck

Covered Most By

Local News Publishers

Top Merck News

Merck urges science-led US vaccine schedule after CDC trims childhood vaccine list

Trump Struck Deals with 16 Drug Companies. But They’re Still Raising Prices This Year

BMS Tries Again With T Cell Engagers, Turning to Janux to Develop New Tumor-Activated Therapy

BMS Tries Again With T Cell Engagers, Turning to Janux to Develop New Tumor-Activated Therapy

Global Blockbuster Drug Landscape Shifts in 2026: Keytruda Defends No. 1, “Diabesity” Rivals Surge, IRA Price Caps Take Effect

Merck CEO on US Business, Life Sciences Innovation

Liz Weston: What Is a ‘Advanced Designation Representative’ and Must I Choose One?

Dow Jones Today: Dow slips as options expiry hits and investors weigh bank earnings

Trump Struck Deals with 16 Drug Companies. But They’re Still Raising Prices This Year

JPM: Illumina Launches 'Unprecedented' Disease Biology Atlas

Merck urges science-led US vaccine schedule after CDC trims childhood vaccine list

Merck in Talks to Buy Biotech Revolution in up to $32 Billion Deal, FT Reports

Trump Announces Lower Drug Price Deals With 9 Pharmaceutical Companies

Covered Most By

Media Bias Breakdown

Breaking News Topics Related to Merck

BMS Tries Again With T Cell Engagers, Turning to Janux to Develop New Tumor-Activated Therapy

Global Blockbuster Drug Landscape Shifts in 2026: Keytruda Defends No. 1, “Diabesity” Rivals Surge, IRA Price Caps Take Effect

Merck CEO on US Business, Life Sciences Innovation

Liz Weston: What Is a ‘Advanced Designation Representative’ and Must I Choose One?

Dow Jones Today: Dow slips as options expiry hits and investors weigh bank earnings

Trump Struck Deals with 16 Drug Companies. But They’re Still Raising Prices This Year

JPM: Illumina Launches 'Unprecedented' Disease Biology Atlas

Merck urges science-led US vaccine schedule after CDC trims childhood vaccine list

Merck in Talks to Buy Biotech Revolution in up to $32 Billion Deal, FT Reports

Trump Announces Lower Drug Price Deals With 9 Pharmaceutical Companies

News about Merck

News about Merck

Covered Most By

Local News Publishers Too Big Arrow Icon

Top Merck News

Merck urges science-led US vaccine schedule after CDC trims childhood vaccine list

Trump Struck Deals with 16 Drug Companies. But They’re Still Raising Prices This Year

BMS Tries Again With T Cell Engagers, Turning to Janux to Develop New Tumor-Activated Therapy

BMS Tries Again With T Cell Engagers, Turning to Janux to Develop New Tumor-Activated Therapy

Global Blockbuster Drug Landscape Shifts in 2026: Keytruda Defends No. 1, “Diabesity” Rivals Surge, IRA Price Caps Take Effect

Merck CEO on US Business, Life Sciences Innovation

Liz Weston: What Is a ‘Advanced Designation Representative’ and Must I Choose One?

Dow Jones Today: Dow slips as options expiry hits and investors weigh bank earnings

Trump Struck Deals with 16 Drug Companies. But They’re Still Raising Prices This Year

JPM: Illumina Launches 'Unprecedented' Disease Biology Atlas

Merck urges science-led US vaccine schedule after CDC trims childhood vaccine list

Merck in Talks to Buy Biotech Revolution in up to $32 Billion Deal, FT Reports

Trump Announces Lower Drug Price Deals With 9 Pharmaceutical Companies

Covered Most By

Media Bias Breakdown

Breaking News Topics Related to Merck

BMS Tries Again With T Cell Engagers, Turning to Janux to Develop New Tumor-Activated Therapy

Global Blockbuster Drug Landscape Shifts in 2026: Keytruda Defends No. 1, “Diabesity” Rivals Surge, IRA Price Caps Take Effect

Merck CEO on US Business, Life Sciences Innovation

Liz Weston: What Is a ‘Advanced Designation Representative’ and Must I Choose One?

Dow Jones Today: Dow slips as options expiry hits and investors weigh bank earnings

Trump Struck Deals with 16 Drug Companies. But They’re Still Raising Prices This Year

JPM: Illumina Launches 'Unprecedented' Disease Biology Atlas

Merck urges science-led US vaccine schedule after CDC trims childhood vaccine list

Merck in Talks to Buy Biotech Revolution in up to $32 Billion Deal, FT Reports

Trump Announces Lower Drug Price Deals With 9 Pharmaceutical Companies

Local News Publishers